Abilify (Aripiprazole)

Medication Information & Treatment Considerations

Abilify (aripiprazole) is a prescription medication that may be considered by a licensed psychiatric provider as part of a treatment plan when clinically appropriate. Treatment recommendations are based on an individual’s symptoms, medical history, treatment goals, and overall clinical evaluation. Individual experiences with medication vary, and treatment outcomes depend on many factors unique to each person. Abilify is not a controlled substance and must be prescribed by a licensed psychiatric provider. Through Telemynd, medication may be prescribed following a secure virtual evaluation when clinically appropriate. Some people may experience side effects such as restlessness, nausea, dizziness, sleep changes, or weight changes. Your provider will monitor your response to treatment and make adjustments as needed.

Important Safety Information

Abilify may increase the risk of suicidal thoughts and behaviors in certain individuals and may increase the risk of metabolic changes, including weight gain and elevated blood sugar. Before starting or changing any medication, discuss potential risks, benefits, side effects, warnings, and drug interactions with your healthcare provider. For complete prescribing information, please review the current FDA-approved prescribing information for Abilify (aripiprazole).

Educational Notice

This content is provided for informational and educational purposes only and should not be considered medical advice or treatment recommendations.

Last reviewed: June 2026.